Company Description
Amgen is among the biggest of the biotech big'uns. And it's determined to get even bigger. The company uses cellular biology and medicinal chemistry...
Key Amgen Financials
| Company Type | Public - NASDAQ (GS): AMGN Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2007 Sales (mil.) | $14,771.0 |
| 2007 Employees | 17,500 |
More Amgen Financials (11 pages)
Latest Amgen Jobs powered by Monster.com
- Medical Information Senior Manager, NB50231429 - Thousand Oaks, CA
- Sr Scientist - NB50234583 - Seattle, WA
- Sr Associate Scientist - Molecular Sciences - NB50233817 - Seattle, WA
Rankings
- #173 in FORTUNE 500
- S&P 500
- #115 in FT Global 500
Competition
Competitive Landscape for Biotechnology Sector
Demand for biotechnology products and services is driven primarily by the willingness of insurers to pay for new medical treatments. The profitability of individual companies depends on the...
Read more about Amgen's competition across multiple industries
Top Amgen Competitors
Sponsored Links
The Business DirectoryAmgen Executives sponsored by genius.com
| Title | Name & Bio | Contact |
|---|---|---|
| Chairman, President, and CEO | Kevin W. Sharer | Network | E-mail |
| EVP Operations | Dennis M. Fenton | Network | E-mail |
| EVP Global Commercial Operations | George J. Morrow | Network | E-mail |
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Amgen News
- Amgen Inc(GAAP) (AMGN.GP) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 02:16:00 EDT)
- Amgen Inc(Alt EPS) (AMGN.AL) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 01:13:00 EDT)
-
Amgen Inc (NASD:AMGN) Weekly Earnings Information [Nelson Information - Weekly Domestic] (17 May 2008 00:23:00 EDT)
Latest Industry Video
-
ASCO 2007 Preview (5:07)
06/01/07 8:50AM ET - Wachovia Capital Markets Senior Biotech Analyst George Farmer and Miller Tabak Pharmaceutical Analyst Les Fundleyder discuss new drugs coming out at this year's conference.





